Final overall survival results and effect of prolonged (≥1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial

By Smith Ian  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 133-143

Springer Publishing Company

Access to resources Recommend Favorite

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

By Nakamura Seigo  

Breast Cancer, Vol. 17, Iss. 3, 2010-07 ,pp. : 199-204

Springer Publishing Company

Access to resources Recommend Favorite

Overall survival in metastatic breast cancer: always our quest but not necessarily a primary endpoint

By Robert Nicholas  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 9-10

Springer Publishing Company

Access to resources Recommend Favorite

Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials

By Blum Joanne   Kohles Joseph   McKenna Edward   Scotto Nana   Hu Sylvia   Odom Dawn   Kaye James   Glück Stefan  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 431-439

Springer Publishing Company

Access to resources Recommend Favorite

Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988–2003 SEER Data

By Gnerlich Jennifer   Jeffe Donna   Deshpande Anjali   Beers Courtney   Zander Christina   Margenthaler Julie  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2187-2194

Springer Publishing Company

Access to resources Recommend Favorite